Author

K. P. White

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

M. Ray· 2 shared A. Jacobsen Skanderup· 1 shared A. L. K. Tan· 1 shared A. P. Mazar· 1 shared A. Rzhetsky· 1 shared A. V. Ugolkov· 1 shared C. G. Anene-Nzelu· 1 shared C. R. Weber· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Ray

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer

T. Sheng, S. W. T. Ho, W. F. Ooi, C. Xu, M. Xing, N. Padmanabhan, K. K. Huang, L. Ma, M. Ray, Y. A. Guo, S. N. Leng, C. G. Anene-Nzelu, M. M. Chang, M. Razavi-Mohseni, M. Beer, , P. Tan

The paper identifies enhancer heterogeneity in gastric cancer by integrating epigenomic data and functional assays, linking it to genetic and regulatory factors.

bioRxiv · Jun 9, 2021Cancer Biology

Pancreatic adenocarcinoma human organoids share structural and genetic features with primary tumors

I. Romero Calvo, C. R. Weber, M. Ray, M. A. Brown, K. J. Kirby, R. K. Nandi, T. M. Long, S. M. Sparrow, A. V. Ugolkov, W. Qiang, Y. Zhang, T. M. Brunetti, H. L. Kindler, J. P. Segal, A. Rzhetsky, , K. P. White

This study shows that pancreatic cancer organoids closely match primary tumors in molecular features, genetic diversity, and drug responses, suggesting their use in personalized therapy prediction.

bioRxiv · Jun 8, 2018Cancer Biology